• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN
June 13, 2018 10:28 AM EDT
Financing
Pharma

UK bank launch­es £2.5B plan to fund in­no­va­tion, with a spe­cial place for its long-ail­ing biotech scene

John Carroll

Editor & Founder

Can a gov­ern­ment-owned bank loaded with cash help trig­ger a biotech boom in the UK?

We’ll find out.

The British Busi­ness Bank has just un­veiled …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

more like this

  • Mer­ck sends new month­ly oral PrEP to Phase 3 af­ter ear­li­er is­la­travir set­back July 14, 2025
  • Up­dat­ed: GSK's Vi­iV ex­pands li­cens­ing pact to in­clude long-act­ing HIV treat­ment July 14, 2025
  • Karyopharm cuts 20% of staff as it looks at 's­trate­gic al­ter­na­tives' or rais­ing cash July 11, 2025
TRENDING NOW

FDA de­clines to ap­prove Ul­tragenyx's San­fil­ip­po gene ther­a­py, cit­ing man­u­fac­tur­ing is­sues

As­traZeneca posts a piv­otal tri­al win for blood pres­sure pill be­hind $1.3B deal

Take­da’s first-in-class nar­colep­sy drug suc­ceeds in two reg­is­tra­tional stud­ies

Boehringer, LEO ink deal for IL-36 drug; Bay­er’s Keren­dia gets an­oth­er in­di­ca­tion

WHO adds Gilead­'s twice-year­ly in­jec­tion to glob­al PrEP guide­lines

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times